Foreign capital publicly committed to KEK Sanur, Indonesia’s first health-focused Special Economic Zone on 41.26 hectares of the former Grand Inna Bali Beach estate, comes from a short, telling list of countries. Germany is the most concrete case: Hamburg’s Alster Lake Clinic broke ground in January 2024 on a 5,600-square-metre cell-therapy clinic, entering through an Indonesian partner under a cooperation agreement with state developer PT Hotel Indonesia Natour (InJourney group). The developer has also named South Korean, Japanese and Australian healthcare groups among signed partners, plus Mayo Clinic (US) as clinical collaborator to anchor tenant Bali International Hospital.
The distinction that matters: the anchor money is Indonesian state capital, roughly Rp 10.3 trillion led by InJourney with IHC, while foreign investors enter as specialist operators inside infrastructure already paid for. The Alster Lake Clinic deal is the clearest public template of how a foreign medical operator gets in: a local partner entity, a land-utilisation agreement with the developer, and a clinical concept the Indonesian market does not yet supply at home.
Why foreign operators are looking at Sanur at all
KEK Sanur was established by Government Regulation No. 41 of 2022 as a health and tourism SEZ in Denpasar, built to solve a specific problem: Indonesians leave for medical care abroad in large numbers, an estimated two million patients and roughly US$11 billion a year, mostly to Malaysia and Singapore. The zone was inaugurated in June 2025 with Bali International Hospital as anchor, run by IHC (Pertamina Bina Medika) with clinical collaboration from Mayo Clinic. Official projections, read as targets rather than guarantees, speak of roughly 43,000 jobs and up to US$1.28 billion in economic contribution by 2045. The practical draw: tax holidays, import and VAT facilities, and an easier path to hiring foreign medical specialists than elsewhere in Indonesia. Verify current terms before committing capital.
The investor mix, country by country
Germany: the operator that actually broke ground
Alster Lake Clinic (ALC) of Hamburg is the case referenced most, because it moved past MOU stage into construction. The clinic is developed by PT Asoka Bunga Khatulistiwa, an Indonesian company working with ALC Germany, on Lot H3C, about 5,600 square metres inside the zone. Groundbreaking took place on 30 January 2024 in a ceremony attended by then State-Owned Enterprises Minister Erick Thohir. Indonesian business media reported the investment at around Rp 500 billion.
South Korea and Japan: agreement stage, not yet built
The developer has named South Korean surgical and nursing-home operators, and Japanese immunology and preventive-screening groups (an export of Japan’s ningen dock check-up culture), among signed partners. Both suit a wellness destination, but as of this writing remain announced partnerships, not visible construction: credible pipeline, not completed investment, until a groundbreaking follows.
The United States and Australia: collaboration, not construction
Two entries are often misread. Mayo Clinic’s role with Bali International Hospital is advisory, a clinical collaboration, not an equity investment or a Mayo-operated hospital. Australian participation is reported in the fertility-clinic segment, also at partnership stage: foreign expertise attaching to Indonesian capital, not replacing it.
The Alster Lake Clinic case, read as a template
Entry vehicle. ALC did not buy land; SEZ land stays under the state developer’s control, and positions are taken through long-term utilisation agreements. The German clinical brand entered through an Indonesian corporate partner holding the agreement with PT Hotel Indonesia Natour. Operators planning a direct position typically hold their Indonesian side through a foreign-owned company, a route covered in our guide to PT PMA setup for KEK Sanur.
Niche, scale and speed. ALC’s focus is cell-based regenerative and preventive medicine, a service line Indonesians currently fly to Germany, Switzerland or Singapore to access, under the scientific direction of Prof. Fred Fändrich of University Medical Center Schleswig-Holstein, with an Indonesian medical director and a GMP-certified laboratory. At 5,600 square metres it is a boutique clinic, not a hospital, within reach of mid-sized foreign clinic groups and physician-led consortia rather than only state-linked capital; the category sits in an evolving regulatory space any entrant must verify with the Health Ministry. Because roads, utilities and infrastructure were financed by the state, ALC’s path from agreement to groundbreaking was measured in months, not years; the developer relationship, not construction, is the long pole.
What the next wave should take from this
The realistic openings now are specialist clinics (diagnostics, fertility, dental, rehabilitation, aesthetics), laboratory and pharmacy services, medical-adjacent hospitality, and recovery accommodation: positions that complement rather than duplicate Bali International Hospital. The sequence that worked for the German entrant, feasibility first, corporate vehicle second, developer negotiation third, licensing and build last, is the one we recommend clients follow. Our medical tourism business entry advisory exists for this stage: as a desk under Juara Holding Group (operating in Bali since 2015), we do not own or operate zone facilities, but coordinate the feasibility work, introductions, and licensed advisors a foreign operator needs before committing capital.
Watch three things: whether Korean and Japanese agreements convert into groundbreakings, how quickly the hospital’s patient volumes build, and how regulators clarify rules around cell-based and other frontier therapies.
This guide is general information, not financial or legal advice. Verify current regulations with licensed advisors.
To discuss a KEK Sanur entry scenario against current zone availability, message the desk on WhatsApp at +62 811-3941-4563 or email bd@juaraholding.com.